Jazz Pharmaceuticals plc Income Statement

1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2009 Dec2010 Dec2011 Dec2012 Mar2013 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 128.45M173.78M272.28M585.98M124.50M872.42M1,172.88M1,324.80M1,487.97M1,618.69M1,890.92M2,161.76M2,363.57M3,094.24M3,659.37M3,834.20M4,068.95M
Cost of Revenue 9.64M13.56M13.94M78.42M102.15M117.42M102.53M105.39M110.19M121.54M127.93M148.92M440.76M540.52M435.58M445.71M
Gross Profit 118.81M160.22M258.33M507.55M770.28M1,055.46M1,222.28M1,382.59M1,508.51M1,769.38M2,033.83M2,214.65M2,653.48M3,118.86M3,398.63M3,623.24M
Operating items
Amortization - Intangibles 7.67M7.83M7.45M65.35M79.04M126.58M98.16M101.99M152.06M201.50M354.81M259.58M525.77M599.17M608.28M627.31M
Research & Development 36.56M25.61M14.12M20.48M41.63M85.18M135.25M162.30M198.44M226.62M299.73M335.38M505.75M590.45M849.66M884.00M
Selling, General & Administrative 58.65M69.00M108.94M223.88M304.30M406.11M449.12M502.89M544.16M683.53M736.94M854.23M1,451.68M1,416.97M1,343.11M1,385.29M
Restructuring Costs 28.8018.2013.60
Other Operating Expenses 17.31M21.38M21.39M143.78M186.18M485.99M232.21M231.13M347.25M365.94M592.72M795.89M966.53M1,717.48M1,062.86M1,083.03M
Operating Expenses 112.52M115.99M144.45M388.13M532.11M977.29M816.58M896.32M1,089.85M1,276.08M1,629.39M1,985.49M2,923.96M3,724.90M3,255.62M3,352.32M
Operating Income 15.93M57.79M127.83M197.84M340.31M195.59M508.22M591.65M528.84M614.84M532.37M378.07M170.28M-65.53M578.58M716.63M
EBIT 15.93M57.79M127.83M197.84M340.31M195.59M508.22M591.65M528.84M614.84M532.37M378.07M170.28M-65.53M578.58M716.63M
Non-operating items
Interest & Investment Income 0.03M-12.72M-1.60M-16.87M-26.92M-52.71M-56.92M-61.94M-77.76M-78.50M-72.26M-99.71M-278.77M-288.24M-289.44M-238.10M
Other Non Operating Income -12.29M-1.25M-3.62M-1.70M8.68M1.45M3.37M-9.97M-6.88M-5.81M-3.27M-4.35M-19.01M8.79M-8.18M
Non Operating Income -1.70M8.68M1.45M
Net income details
EBT 0.01M32.78M124.98M177.35M307.95M151.56M435.93M532.45M441.12M529.46M454.30M275.10M-112.84M-372.78M297.93M470.35M
Tax Provisions -83.79M91.64M94.23M106.40M135.24M-47.74M80.20M-73.20M33.52M216.12M-158.65M-119.91M-91.43M
Profit After Tax 6.84M32.78M124.98M288.59M216.31M58.39M329.54M396.83M487.85M447.10M523.37M238.62M-329.67M-224.06M414.83M560.12M
Equity Income -0.38M-1.01M-2.20M-4.09M-2.96M-0.71M-9.92M-3.01M-1.66M
Income from Non-Controlling Interests -1.06M-0.00M
Income from Continuing Operations 0.01M32.78M124.98M261.15M216.31M57.33M329.53M397.21M488.86M449.26M527.50M241.58M-328.95M-214.14M417.84M561.78M
Consolidated Net Income 0.01M32.78M124.98M27.44M216.31M57.33M329.53M397.21M488.86M449.26M527.50M241.58M-328.95M-214.14M417.84M561.78M
Income towards Parent Company 0.01M32.78M124.98M27.44M216.31M57.33M329.53M397.21M488.86M449.26M527.50M241.58M-328.95M-214.14M417.84M561.78M
Net Income towards Common Stockholders 6.84M32.78M124.98M27.44M216.31M57.33M329.53M397.21M488.86M449.26M527.50M241.58M-328.95M-214.14M417.84M561.78M
Additional items
EPS (Basic) -0.230.903.015.093.710.985.386.568.137.459.224.28-5.52-3.586.559.06
EPS (Weighted Average and Diluted) -0.230.832.674.793.510.935.236.417.967.309.094.22-5.52-3.586.108.65
Shares Outstanding (Weighted Average) 30.99M38.92M42.16M58.04M58.04M57.79M60.49M61.50M59.89M59.95M60.32M56.57M55.71M61.47M62.97M62.96M60.45M
Shares Outstanding (Diluted Average) 39.41M46.80M60.20M61.51M61.57M62.61M63.04M61.87M61.32M61.22M57.55M56.52M59.69M62.54M72.07M66.01M
EBITDA 15.93M57.79M127.83M197.84M340.31M195.59M508.22M591.65M528.84M614.84M532.37M378.07M170.28M-65.53M578.58M716.63M
Interest Expenses 22.80M3.62M1.70M13.7022.7022.1030.00
Tax Rate 29.76%62.18%24.41%25.40%15.15%12.18%42.56%